Single-Use Bioprocessing APAC 2028

Biopharmaceutical manufacturing across Asia-Pacific is evolving towards greater flexibility, speed and operational agility, as manufacturers respond to increasingly diverse pipelines, changing production volumes and the need to bring new therapies to patients more efficiently. Single-use technologies are playing an increasingly important role in this transformation, enabling more flexible facility designs, faster changeovers and adaptable manufacturing strategies across clinical and commercial production.

Across Singapore, South Korea, Japan, China, Taiwan, India and Southeast Asia, biopharmaceutical manufacturers and CDMOs continue to expand and modernise their manufacturing capabilities. As facilities become more flexible and multi-product, the industry is increasingly focused on how single-use systems can be effectively implemented, scaled and integrated while addressing challenges around process robustness, automation, supply security, extractables and leachables, sustainability and regulatory compliance.

Taking place on 16–17 May 2028 in Singapore, Single-Use Bioprocessing APAC 2028 will bring together biopharmaceutical manufacturers, CDMOs, technology providers and industry experts from across Asia-Pacific to explore the latest strategies and technologies shaping the future of single-use bioprocessing from process development and facility design through to commercial-scale manufacturing.

The conference will explore single-use upstream and downstream processing, fluid management, mixing, filtration, process intensification, facility and process design, automation and digital integration, extractables and leachables, supply-chain resilience and sustainability — providing a focused platform for the industry to exchange practical experience, discover new technologies and advance the next generation of flexible biopharmaceutical manufacturing across APAC.